Tien-Li Lee reports a stock award and shares returned to the company
By AlphaYouPublished Form 4
Lee Tien-Li
Reporting filer
Tien-Li Lee reports a stock award and shares returned to the company, not an open-market purchase or sale, in Aardvark Therapeutics, Inc.. Form 4 filed Nov 10, 2026 lists 6 entries.
- Disclosed
- Nov 10, 2026
Reported details
6 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | A | Grant or award | 203851 | Not stated (see footnotes) | 203,851 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | D | Disposition to issuer | 203851 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | A | Grant or award | 549534 | Not stated (see footnotes) | 549,534 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | D | Disposition to issuer | 549534 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | A | Grant or award | 40566 | Not stated (see footnotes) | 40,566 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Lee Tien-Li | 2026-11-06 | D | Disposition to issuer | 40566 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 203851
- Price
- Not stated (see footnotes)
- Following holdings
- 203,851
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 1.26
- id: F1
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 203851
- id: F3
- id: F4
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-02-09
- underlying Security Title: Common Stock
- underlying Security Shares: 203851
- shares Owned Following Transaction: 203851
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 203851
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 13.48
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: false
- transaction Shares: 203851
- id: F3
- id: F4
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2036-02-09
- underlying Security Title: Common Stock
- underlying Security Shares: 203851
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 549534
- Price
- Not stated (see footnotes)
- Following holdings
- 549,534
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 1.26
- id: F5
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 549534
- id: F3
- id: F4
- transaction Acquired Disposed Code: A
- id: F6
- expiration Date: 2035-06-11
- underlying Security Title: Common Stock
- underlying Security Shares: 549534
- shares Owned Following Transaction: 549534
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 549534
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 11.29
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: false
- transaction Shares: 549534
- id: F3
- id: F4
- transaction Acquired Disposed Code: D
- id: F6
- expiration Date: 2035-06-11
- underlying Security Title: Common Stock
- underlying Security Shares: 549534
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- A
- Action
- Grant or award
- Quantity
- 40566
- Price
- Not stated (see footnotes)
- Following holdings
- 40,566
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 1.26
- id: F7
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 40566
- id: F3
- id: F4
- transaction Acquired Disposed Code: A
- id: F8
- expiration Date: 2034-07-20
- underlying Security Title: Common Stock
- underlying Security Shares: 40566
- shares Owned Following Transaction: 40566
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- Lee Tien-Li
- Date
- 2026-11-06
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 40566
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 4.24
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: false
- transaction Shares: 40566
- id: F3
- id: F4
- transaction Acquired Disposed Code: D
- id: F8
- expiration Date: 2034-07-20
- underlying Security Title: Common Stock
- underlying Security Shares: 40566
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Lee Tien-Li: Chief Executive Officer, Director, 10% owner.
- F1: If this option is exercised prior to the end of the Retention Period (as defined in footnote (3)), the exercise price per share for such exercise shall be $13.48, the original exercise price per share, and not the New Exercise Price (as defined in footnote (3)) reflected in Column 2.
- F2: 1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
- F3: On August 14, 2026, the stockholders of the Issuer approved a proposal to reprice certain eligible outstanding stock options, including the stock options with exercise prices of $13.48, $11.29 and $4.24 listed in Table II (the "Repriced Options"). In accordance with this approval, on November 6, 2026, the exercise price of each Repriced Option was reduced to $1.26 (the "New Exercise Price"); provided that, for the New Exercise Price to apply, the Reporting Person must remain in Continuous Service (as defined in the applicable equity plan governing such option) with the Issuer from November 6, 2026 until the earlier of (i) November 6, 2027 and (ii) a Change in Control (as defined in the applicable equity plan governing such option) during the Reporting Person's Continuous Service with the Issuer (upon which such option shall accelerate in full) (such period, the "Retention Period").
- F4: (Continued from footnote 3) Following the repricing, each Repriced Option retains its respective original vesting schedule and expiration date.
- F5: If this option is exercised prior to the end of the Retention Period, the exercise price per share for such exercise shall be $11.29, the original exercise price per share, and not the New Exercise Price reflected in Column 2.
- F6: 1/4th of the shares subject to the option vested on June 11, 2026, and 1/48th of the shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
- F7: If this option is exercised prior to the end of the Retention Period, the exercise price per share for such exercise shall be $4.24, the original exercise price per share, and not the New Exercise Price reflected in Column 2.
- F8: 1/48th of the original number of shares subject to the option vested on July 27, 2024, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.
Original sources
Prepared automatically from public filing data. Report a correction.